ArticlePlant biotechnology journal2026
Transcriptional Regulation of the Novel Theacrine Synthase Gene CsTcS2 by the CsTINY-CsWRKY33 Module Underpins Theacrine Biosynthesis in Camellia sinensis.
Article in Plant biotechnology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Transcriptomic and biochemical analyses revealed the dynamic regulatory mechanisms underlying leaf morphogenesis inFrontiers in plant science · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
Theacrine (1,3,7,9-tetramethyluric acid) is a purine alkaloid detected in multiple wild and specialised tea germplasms (Camellia sinensis) from South China, including Kucha. However, the molecular mechanisms governing its biosynthesis remain poorly understood. Here, we identify CsTcS2 as a novel theacrine synthase in tea plant. Functional assays involving heterologous expression in Nicotiana benthamiana, antisense oligonucleotide-mediated gene silencing, transient overexpression in tea plants and co-expression with caffeine dehydrogenase (CsCDH) confirm its catalytic role in converting caffeine to theacrine. Transcription factors CsTINY and CsWRKY33 directly bind the CsTcS2 promoter and activate its transcription, as demonstrated by yeast one-hybrid, dual-luciferase reporter and electrophoretic mobility shift assays. Further molecular docking, yeast two-hybrid, bimolecular fluorescence complementation, luciferase complementation, co-immunoprecipitation and antisense inhibition experiments reveal a synergistic interaction between CsTINY and CsWRKY33 that regulates CsTcS2 expression and thus controls theacrine biosynthesis. Together, our findings unravel the transcriptional regulatory network underlying theacrine biosynthesis and provide a molecular foundation for breeding tea cultivars with elevated theacrine levels for health-promoting applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.